A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

@article{Serruys2015ABE,
  title={A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial},
  author={Patrick W.J.C. Serruys and Bernard Chevalier and D Dipl-Chem Dr Dudek and Angel Cequier and Yoshinobu Onuma},
  journal={The Lancet},
  year={2015},
  volume={385},
  pages={43-54}
}
BACKGROUND Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for treatment for coronary artery disease, no data from comparisons with its metallic stent counterpart are available. In a randomised controlled trial we aimed to compare an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent. Here we report secondary clinical and procedural outcomes after 1 year of follow-up. METHODS In a single-blind, multicentre, randomised trial, we… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 201 CITATIONS

Textbook of Catheter-Based Cardiovascular Interventions

  • Springer International Publishing
  • 2018
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Bioresorbable Vascular Scaffold Thrombosis: Solutions to the Problem?

  • JACC. Cardiovascular interventions
  • 2017
VIEW 4 EXCERPTS
CITES METHODS & RESULTS
HIGHLY INFLUENCED

The benefits of drug-eluting stents in the treatment of coronary artery disease

VIEW 4 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

Fully bioresorbable scaffolds for coronary artery disease

VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea

  • The Korean journal of internal medicine
  • 2017
VIEW 13 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.

  • Journal of the American College of Cardiology
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2013
2019

CITATION STATISTICS

  • 18 Highly Influenced Citations

  • Averaged 46 Citations per year over the last 3 years

Similar Papers

Loading similar papers…